Quantitative Systematic Strategies’s Iovance Biotherapeutics IOVA Stock Holding History

Quantitative Systematic Strategies’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,157	Closed	-$116K	–	517
2019 Q1	$116K	Sell	12,157 -918	-7%	-$8.92K	0.03%	349
2018 Q4	$116K	Buy	+13,075	New	+$126K	0.03%	596
2016 Q3	–	Sell	-22,452	Closed	-$178K	–	419
2016 Q2	$178K	Buy	+22,452	New	+$141K	0.08%	302
2015 Q2	–	Sell	-34,423	Closed	-$416K	–	558
2015 Q1	$416K	Buy	+34,423	New	+$388K	0.11%	246

Other funds holding IOVA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Quantitative Systematic Strategies's IOVA Position: Q2 2019 in Review

Quantitative Systematic Strategies sold out of Iovance Biotherapeutics (IOVA) in Q2 2019, closing a stake of 12,157 shares — an estimated $116K sold.

Quantitative Systematic Strategies first reported a position in IOVA in Q1 2015 and held it in 4 quarters. The position peaked at $416K in Q1 2015. 167 funds tracked by Wall St. Rank hold IOVA as of Q2 2019.

Quantitative Systematic Strategies reported no remaining Iovance Biotherapeutics position as of Q2 2019 after selling out during the quarter.
Quantitative Systematic Strategies sold 12,157 Iovance Biotherapeutics shares in Q2 2019, an estimated $116K.
Quantitative Systematic Strategies first reported a position in Iovance Biotherapeutics in Q1 2015 and held it in 4 quarters.
Quantitative Systematic Strategies's Iovance Biotherapeutics position peaked at $416K in Q1 2015.
167 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2019, filed 25 Jul 2019.